Seeking AlphaWed, 10 Jun 2026 15:42:11 GMTMaze Therapeutics, Inc. (MAZE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptMAZE+0.98%
Zacks Investment ResearchTue, 12 May 2026 22:16:10 GMTMaze Therapeutics, Inc. (MAZE) Reports Q1 Loss, Beats Revenue EstimatesMAZE+0.98%
The Motley FoolSat, 04 Apr 2026 23:36:00 GMTMaze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.MAZE+0.98%
Seeking AlphaFri, 27 Mar 2026 19:09:00 GMTMaze Therapeutics: MZE829 Presses Forward Despite Stock Price DropMAZE+0.98%
Zacks Investment ResearchFri, 27 Mar 2026 14:37:11 GMTAfter Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Maze Therapeutics, Inc. (MAZE)MAZE+0.98%
